REG - Indivior PLC - Transaction in Own Shares

IndiviorAnnouncement

24/12/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241224:nRSX1731Ra&default-theme=true

RNS Number : 1731R  Indivior PLC  24 December 2024

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

December 24, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 209,246 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from December 16, 2024, up to and
including December 20, 2024, in connection with its $100m Share Repurchase
Program. Aggregated information on the purchase of these shares can be found
in the table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 125,062,916 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (125,062,916) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 16/12/2024    LSE            16,243                                      920.78
 16/12/2024    BATE           6,034                                       919.89
 16/12/2024    CHIX           16,371                                      919.54
 16/12/2024    AQUIS          3,123                                       916.77
 17/12/2024    LSE            25,718                                      931.58
 17/12/2024    BATE           5,231                                       931.09
 17/12/2024    CHIX           16,759                                      930.15
 17/12/2024    AQUIS          821                                         926.66
 18/12/2024    LSE            14,770                                      942.76
 18/12/2024    BATE           6,911                                       941.62
 18/12/2024    CHIX           15,222                                      942.22
 18/12/2024    AQUIS          2,465                                       942.17
 19/12/2024    LSE            16,217                                      910.35
 19/12/2024    BATE           4,669                                       908.69
 19/12/2024    CHIX           16,156                                      911.69
 19/12/2024    AQUIS          1,697                                       912.18
 20/12/2024    LSE            16,317                                      912.01
 20/12/2024    BATE           6,705                                       908.38
 20/12/2024    CHIX           14,161                                      908.16
 20/12/2024    AQUIS          3,656                                       918.09

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSFZMZZKFGGDZM